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First, the Cox's proportional hazard model expresses the prob-
ability of survival at time t, given an X vector of covariates, as:
(2-4),
where So(t), the survivor function for I3TX = 0, is usually estimated
with Breslow's method (5) and differs slightly from the Kaplan-
Meier estimates. Thus, computation of an absolute probability of
survival with Cox's model needs the knowledge of the score I3TX
and of the underlying survivor function So(t).
These functions may differ in groups I, 2 and 3, because
differences are noted for Kaplan-Meier estimates of I year survival
for these three groups (210/260 = 81%, 734/886 = 83% and
5011582 = 86%, respectively). Such differences may account in
part for the overestimation of deaths in groups 2 and 3 by the
Cox model. Does the overestimation persist, when using the I3TX
score to compute a relative (and not absolute as in Fig. I) risk of
death, weighted by the respective survivor functions of groups 2
and 3?
Second, the accuracy (6) of the three investigated methods is
reported only for one arbitrary end point. A more detailed display,
as provided by ROC curves (7), could be of interest. This point
is of clinical relevance: some physicians may be concerned by the
detection of a very high risk group (for example, high specificity
for the prognosis of death) and others by the detection of a very
low risk group.
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Reply
The Cox model was developed in the first group of 260 patients
(group I) and we did not perform the analysis again in the two
later groups (groups 2 and 3). The model was only tested in these
groups of patients, Therefore, we can only present an underlying
survivor function for group 1. The function was So(t) = 0.807.
The score I3TX can be calculated for each patient by utilizing the
regression coefficients in Table I.
I agree that slightly differing underlying survivor functions in
groups 2 and 3 could account in part for the overestimation of
deaths. In calculating the expected number of deaths in each subgroup
(Table 3) we used the estimated risk of death (Fig. I), which was
based on the underlying survivor function for group I. We believe
that this approach provides a fair method for testing the developed
model in a new study group. It is unfortunately not possible to
repeat the analyses with the survivor functions for groups 2 and
3.
We have considered the use of ROC analysis, but this would
be valid only for the Cox analysis. Table 5 presents the classifi-
cation accuracy in the low and high risk ends of the scale. Since
one purpose was to compare the Cox model with discriminant
function analysis and recursive partitioning, we did not include
ROC curves. The classification criteria were fixed for both the
resubstitutions and tests in the three groups of patients. If ROC
were applied, these criteria would change and this would not give
a fair comparison. In addition, ROC curves would not be valid
for discriminant function analysis because discrete variables were
included in the score calculation.
ERLING BIRK MADSEN, MD
Medical Department B
Rigshospitalet
DK-2JOO Copenhagen
Denmark
DVI Versus VVI Pacing in Heart Block With
Low Cardiac Output
With reference to the report by Rietveld et al. (I), it has been
my experience that patients with important heart block (either 2: I
atrioventricular [AVj block or complete heart block and a slow
ventricular rate) with a low cardiac output state due to dominant
right ventricular infarction frequently respond poorly to VVI pac-
ing. On the other hand, the response to DVI pacing can be dramatic
and I think life-saving. We are so often concerned with increasing
the ventricular rate that we tend to forget or underestimate the
contribution the atrium makes to cardiac output.
I have also used atrial pacing in a patient with inferior wall
infarction and predominant right ventricular damage which was
complicated by nodal bradycardia, hypotension and oliguria. VVI
pacing in this patient did nothing except increase the ventricular
rate, whereas atrial pacing reversed the situation.
An important factor when considering a DVI pacemaker is the
patient's atrial rate. I have had the misfortune to place a DVI
pacemaker in a patient with inferior myocardial infarction and
complete heart block with dominant right ventricular damage, only
to find I was unable to capture the atrium. Careful inspection of
the initial electrocardiogram revealed that the patient had an un-
derlying sinus tachycardia.
Rietveld's patient had a severe additional problem in the form
of a previously undiagnosed atrial septal defect, which was ob-
viously an important factor. However, in my opinion we should
offer these patients the best physiologically possible pacing, and
that is a temporary AV sequential pacemaker.
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